References
- Heikkinen T, Chonmaitree T. Importance of respiratory viruses in acute otitis media. Clin Microbiol Rev 2003;16:230–41.
- Japan Otological Society, Japan Society for Pediatric Otorhinolaryngology, Japan Society for Infection and Aerosol in Otorhinolaryngology. 2013. Clinical practice guidelines for the diagnosis and management of acute otitis media (AOM) in children in Japan 2013. Tokyo: Kanehara & Co.
- Barkai G, Leibovitz E, Givon-Lavi N, Dagan R. Potential contribution by nontypeable Haemophilus influenzae in protracted and recurrent acute otitis media. Pediatr Infect Dis J 2009;28:466–71.
- Clementi CF, Murphy TF. Non-typeable Haemophilus influenzae invasion and persistence in the human respiratory tract. Front Cell Infect Microbial 2011;1:1–9.
- Dagan R, Leibovitz E, Greenberg D, Bakaletz L, Givon-Lavi N. Mixed Pneumococcal-nontypeable Haemophilus influenza otitis media is a distinct clinical entity with unique epidemiologic characteristics and pneumococcal serotype distribution. J Infect Dis 2013;208:1152–60.
- Hall-Stoodley L, Hu FZ, Gieseke A, Nistico L, Nguyen D, Hayes J, et al. Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media. JAMA 2006;296:202–11.
- Nakamura S, Yanagihara K, Araki N, Yamada K, Norinaga Y, Izumikawa K, et al. Efficacy of clarithromycin against experimentally induced pneumonia caused by clarithromycin-resistant Haemophilus influenzae in mice. Antimicrob Agents Chemother 2010;5:757–62.
- Uemura Y, Qin Y, Gotoh K, Ohta K, Nakamura K, Watanabe H. Comparison study of single and concurrent administrations of carbapenem, new quinolone, and macrolide against in vitro nontypeable Haemophilus influenzae mature biofilm. J Infect Chemother 2013;19:902–8.
- Rosenfeld RM, Kay D. Natural history of otitis media. Laryngoscope 2003;113:1645–57.
- Kudoh S, Uetake T, Hagiwara K, Hirayama M, Hus LH, Kimura H, et al. [Clinical effects of low-dose long-term erythromycin chemotherapy on diffuse panbronchiolitis.]. Nihon Kyobu Shikkan Gakkai Zasshi 1987;25:632–42; in Japanese.
- Cervin A, Wallwork B. Macrolide therapy of chronic rhinosinusitis. Rhinology 2007;45:259–67.
- Hori F, Kawauchi H, Mogi G. Effect of S-carboxymethylcysteine on the clearance of middle ear effusion. An experimental study. Ann Otol Rhinol Laryngol 1994;103:567–75.
- Moore RA, Commins D, Bates G. S-carboxymethylcysteine in the treatment of glue ear: quantitative systematic review. BMC Fam Pract 2001;2:3.
- Hotomi M, Yamanaka N, Shimada J, Ikeda Y, Faden H. Factors associated with clinical outcome in acute otitis media. Ann Otol Rhinol Laryngol 2004;113:846–52.
- Chen K, Wu X, Jiang G, Du J, Jiang H. Low dose macrolide administration for long term is effective for otitis media with effusion in children. Auris Nasus Larynx 2013;40:46–50.
- Statham MM, Seiden A. Potential new avenues of treatment for chronic rhinosinusitis: an anti-inflammatory approach. Otolaryngol Clin North Am 2005;38:1351–65.
- Shinkai M, Henke MO, Rubin BK. Macrolide antibiotics as immunomodulatory medications; proposed mechanisms of action. Pharmacol Ther 2008;117:393–405.
- Kitano M, Ishinaga H, Shimizu T, Takeuchi K, Majima Y. Effect of clarithromycin and dexamethasone on mucus production in isografted rat trachea. Pharmacology 2011;87:56–62.
- Fujita K, Shimizu T, Majima Y, Sakakura Y. Effects of macrolides on interleukin-8 secretion from human nasal epithelial cells. Eur Arch Otorhinolaryngol 2000;257:199–204.
- Takaki M, Ushikai M, Deguchi K, Nishimoto K, Matsune H, Kurono Y. The role of nuclear factor-kappa B in interleukin-8 expression by human adenoidal fibroblasts. Laryngoscope 2003;113:1378–85.